242 related articles for article (PubMed ID: 12584525)
21. Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study.
Hammana I; Coderre L; Potvin S; Costa M; Berthiaume Y; Lavoie A; Chiasson JL; Levy E; Rabasa-Lhoret R
J Cyst Fibros; 2009 Mar; 8(2):128-34. PubMed ID: 19083274
[TBL] [Abstract][Full Text] [Related]
22. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
23. [Cystic fibrosis diabetes in adult].
Vantyghem MC; Moussaïd-Guennoun R; Perimenis P; Marcelli-Tourvieille S; Perez T; Wallaert B
Ann Endocrinol (Paris); 2005 Sep; 66(4):347-54. PubMed ID: 16392185
[TBL] [Abstract][Full Text] [Related]
24. [Consensus on the diagnosis and management of changes in carbohydrate metabolism in cystic fibrosis].
Barrio Castellanos R ; Cos Blanco A ; García García E ; Gussinyé Cañadell M ; Merino Torres J ; Muñoz Calvo M
An Esp Pediatr; 2000 Dec; 53(6):573-9. PubMed ID: 11148156
[TBL] [Abstract][Full Text] [Related]
25. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
[TBL] [Abstract][Full Text] [Related]
26. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.
Allen HF; Gay EC; Klingensmith GJ; Hamman RF
Diabetes Care; 1998 Jun; 21(6):943-8. PubMed ID: 9614612
[TBL] [Abstract][Full Text] [Related]
27. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
Mohan V; Shanthirani CS; Deepa R
J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
[TBL] [Abstract][Full Text] [Related]
28. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
Moheet A; Moran A
Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis.
Jensen P; Johansen HK; Carmi P; Høiby N; Cohen IR
J Autoimmun; 2001 Sep; 17(2):165-72. PubMed ID: 11591125
[TBL] [Abstract][Full Text] [Related]
30. Abnormal glucose tolerance in CF--when should we offer diabetes treatment?
Moran A
Pediatr Diabetes; 2009 May; 10(3):159-61. PubMed ID: 19422601
[No Abstract] [Full Text] [Related]
31. How to assess for impaired glucose tolerance before transplantation and should these results influence the choice of calcineurin inhibitors?
Filler G; Hadjiyannakis S
Pediatr Transplant; 2006 Feb; 10(1):1-4. PubMed ID: 16499579
[No Abstract] [Full Text] [Related]
32. Post-renal transplant diabetes in Sri Lanka.
Lanerolle RD; de Abrew K; Fernando DJ; Sheriff MH
Transplant Proc; 1996 Jun; 28(3):1945-7. PubMed ID: 8658956
[No Abstract] [Full Text] [Related]
33. Response to Allen et al. and Holl et al.
Yung B
Diabetes Care; 1998 Dec; 21(12):2199-200. PubMed ID: 9839125
[No Abstract] [Full Text] [Related]
34. Diabetes mellitus in cystic fibrosis.
Lanng S
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):744-7. PubMed ID: 8864669
[TBL] [Abstract][Full Text] [Related]
35. Combined Indeterminate and Impaired Glucose Tolerance Is a Novel Group at High Risk of Cystic Fibrosis-Related Diabetes.
Potter KJ; Reynaud Q; Boudreau V; Racine F; Tremblay F; Lavoie A; Carricart M; Mailhot G; Durieu I; Senior PA; Rabasa-Lhoret R
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3901-e3910. PubMed ID: 34132785
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiologic characters of diabetic mellitus in urban and rural community in 2003 in Hangzhou City].
Xu WM; Jin XY; Zhu XX; Tian JS; Wu LM; Jiang HR; Ye JJ; Shi SF; Feng SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):729. PubMed ID: 15555406
[No Abstract] [Full Text] [Related]
37. Use of "glucola alternatives" for cystic fibrosis-related diabetes screening.
Franco WB; Brown RF; Bremer AA
J Cyst Fibros; 2011 Sep; 10(5):384-5. PubMed ID: 21703944
[No Abstract] [Full Text] [Related]
38. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero.
Tam WH; Ma RC; Yang X; Ko GT; Tong PC; Cockram CS; Sahota DS; Rogers MS; Chan JC
Pediatrics; 2008 Dec; 122(6):1229-34. PubMed ID: 19047239
[TBL] [Abstract][Full Text] [Related]
39. [Newly diagnosed abnormal glucose tolerance in patients with acute coronary syndrome and without known diabetes mellitus].
Yan MZ; Hu DY; Yu JM; Sun YH; Liu WL;
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1256-9. PubMed ID: 16796885
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and therapy of cystic fibrosis-related diabetes].
Henke MO; Lang SM; Fischer R; Landgraf R; Huber RM; Bertele-Harms RM; Harms HK
Pneumologie; 2004 Jan; 58(1):36-9. PubMed ID: 14732899
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
